Class-level findings do not guarantee equivalent compound-level outcomes
Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance Hospira, Inc., a Pfizer company, is voluntarily recalling BACTERIOSTATIC WATER for Injection, USP, 30 mL, multi-dose vial, lot W20308, to the Hospital/Retail level
Some patients may experience mild redness and swelling at the injection site as a natural inflammatory response to the injection
In cases of cyanide poisoning, it is typically administered as a single intravenous injection
Injection frequency: AOD 9604 requires daily injection
Most endocrinologists cite 14 days as the conservative limit